German biotech company CureVac said Wednesday that its founder has withdrawn his candidacy for the supervisory board for health reasons.
Dr.
CureVac said that Hoerr “has stated continuing health problems, which do not allow him to resume his duties.”
The company announced disappointing interim results for its coronavirus vaccine earlier this month and the future of the mRNA-based shot is unclear.
Similar technology is used by rivals
© 2021 The Canadian Press. All rights reserved., source